In a recent article published in Nature Cancer, a multi-institutional research team led by The University of Osaka describes ...

Vision is one of the most crucial human senses, yet over 300 million people worldwide are at risk of vision loss due to various retinal diseases.

The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other ...

A super-resolution microscopy technique offers an unparalleled glimpse into how monoclonal antibodies bind to their targets ...

Bispecific antibodies have become component in the arsenal of treatments for hematologic malignancies; management of their side effects is crucial to their success.

Inotuzumab ozogamicin is safe and effective in adult patients with relapsed/refractory B-cell acute lymphoblastic leukaemia, ...

Early tests suggest that an antibody-based therapy is safe, with no harmful effects on healthy cells, suggesting that it ...

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an ...